TGA joins international collaboration to evaluate generic drugs
03 September, 2014The Therapeutic Good Administration (TGA) has joined a pilot of the Decentralised Procedure (DCP) of the European Union - a collaboration on the evaluation of generic drug applications.
Finalists for Qualcomm Tricorder XPRIZE announced
02 September, 2014The finalists for the Qualcomm Tricorder XPRIZE have been announced. The $10 million global competition asks teams to develop a consumer-focused, mobile device capable of diagnosing and interpreting a set of 15 medical conditions and capturing five vital health metrics.
AMS appointed optek distributor
01 September, 2014AMS Instrumentation & Calibration has been appointed the exclusive distributor for the optek range of analytical instrumentation in its territories.
Crowdfunding to test cancer drug on Ebola
01 September, 2014Biotechnology company OncoSynergy has launched a crowdfunding campaign to enable studies of an experimental cancer drug in Ebola infection. It is hoped that the drug may be able to combat the Ebola crisis in west Africa, which has already claimed almost 1500 lives.
AXT to distribute Thermo Fisher Scientific materials analysis products
29 August, 2014Analytical solutions provider AXT has signed an agreement with the Nano-scale Materials Analysis product lines of Thermo Fisher Scientific, whereby AXT will become the company's distributor in Australia and New Zealand for its Surface Analysis and Microanalysis product lines.
2014 Australian Laureate Fellows announced
26 August, 2014The 2014 Australian Research Council (ARC) Australian Laureate Fellowships have been announced by Minister for Education Christopher Pyne. The scheme supports groundbreaking, internationally competitive research that builds Australia's research capacity.
Seeking better ways to do business at ASiX
25 August, 2014The inaugural Australian Science Industry Exchange event (ASiX) was held in Melbourne last week, with over 80 of the country's science sector business and technology leaders discussing the state of the industry and seeking to find better ways to do business.
Merck moving its head office
25 August, 2014The Australian division of life science supplier Merck (Merck Millipore) is moving to a new head office.
BioProcessing Network Conference 2014
22 August, 2014The BioProcessing Network (BPN) is holding its annual conference from 21-23 October at Encore, St Kilda. The meeting will gather together researchers, manufacturers, suppliers and others with an active interest in bioprocessing as it applies to areas such as biotherapeutics, biofuels and food processing.
Australian Genomic Technologies Association conference
21 August, 2014The 14th Australasian Genomic Technologies Association (AGTA) conference will be held at the Crown Promenade, Melbourne, Australia, Sunday 12 to Wednesday 15 October 2014.
2014 Women in Science Fellowship winners announced
20 August, 2014The winners of the 2014 L'Oréal for Women in Science Fellowships have been announced. The fellowships provide $25,000 to early-career female scientists to support them in their specialist area of research.
Hitachi Data Systems awards Intersect Australia
19 August, 2014Hitachi Data Systems has presented eResearch support agency Intersect Australia with the APAC Health and Life Sciences Innovation Award, recognising the company's achievements in fostering collaboration, innovation and efficiencies in the medical research sector.
ACD and Leica Biosystems co-market RNA in situ hybridisation platform
19 August, 2014Leica Biosystems and Advanced Cell Diagnostics are co-marketing ACD's RNAscope LS ISH assays with Leica Biosystems' Bond RX research staining platform. The agreement provides researchers with an integrated and fully automated ISH solution.
Abcam establishes direct service for ANZ
18 August, 2014Protein research tool provider Abcam has established a direct service to Australia and New Zealand. Researchers can now source products and technical support directly from the UK-based company, rather than through distributors, which is expected to improve delivery times and better meet researchers' needs.
Miltenyi Biotec acquires gene therapy assets from Lentigen
18 August, 2014Global biotechnology company Miltenyi Biotec has acquired the lentiviral vector manufacturing business and related assets from US company Lentigen, a provider of lentiviral technology for cell and gene therapy applications.
